Angiogenesis Inhibitors: all 4,430 studies that test it
Page 28 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- A Trial of Endostar in Patients With Carcinoma of the Head and NeckStatus unknownNCT02902432Phase 2
- Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled GlaucomaCompletedNCT02901236Phase 2/3
- Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional StatusCompletedNCT02898012Phase 2
- Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple MyelomaTerminatedNCT02897830Phase 2
- ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+BevacizumabCompletedNCT02891824Phase 3
- Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance StrategyCompletedNCT02891811Phase 2
- A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MMActive, not recruitingNCT02886065Phase 1
- Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look SurgeryActive, not recruitingNCT02884648Phase 2
- Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLCStatus unknownNCT02879097Phase 3
- 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.WithdrawnNCT02878681Phase 4
- Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other TumorsCompletedNCT02876224Phase 1
- The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC PatientsStatus unknownNCT02865304Phase 3
- Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading DoseStatus unknownNCT02864472Phase 4
- EDOCH Alternating With DHAP for New Diagnosed Younger MCLCompletedNCT02858804Phase 4
- Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic RetinopathyCompletedNCT02857491Not applicable
- Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 MeningiomaCompletedNCT02847559Phase 2
- The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WMCompletedNCT02844309Phase 4
- Functional and Structural Outcomes in Neovascular Age-related Macular DegenerationCompletedNCT02843490Phase 4
- Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent GlioblastomaTerminatedNCT02841332Not applicable
- Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)Active, not recruitingNCT02840409Phase 2
- Study of Nintedanib Plus Bevacizumab in Advanced Solid TumorsCompletedNCT02835833Phase 1
- Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade GliomaTerminatedNCT02833701Phase 1
- A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung CancerWithdrawnNCT02831491Phase 2
- Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade GliomasCompletedNCT02829931Phase 1
- Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal CancerCompletedNCT02821559Phase 2
- Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCCStatus unknownNCT02812641Phase 2
- Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung AdenocarcinomaStatus unknownNCT02804646Phase 4
- Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,PanobinostatWithdrawnNCT02802163Phase 1/2
- Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal NeovascularizationTerminatedNCT02797704Phase 1/2
- Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)Status unknownNCT02788877Phase 4
- Conmana Combined With Thalidomide to Treat NSCLCStatus unknownNCT02778893Phase 4
- 3 Month Outcome of Ziv-aflibercept for DMECompletedNCT02772497Phase 2/3
- Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent GlioblastomaCompletedNCT02768389Early Phase 1
- The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy SurgeryCompletedNCT02767219Phase 3
- Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR MutationsCompletedNCT02759614Phase 3
- Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related BleedingWithdrawnNCT02754960Phase 2
- PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US)Status unknownNCT02747823Phase 1
- Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung CancerStatus unknownNCT02743923Phase 3
- Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular EdemaCompletedNCT02734407Phase 4
- Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaStatus unknownNCT02733380Phase 2
- A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple MyelomaActive, not recruitingNCT02718833Phase 2
- A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid TumorsCompletedNCT02715531Phase 1
- Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to SunitinibCompletedNCT02713763Phase 2
- the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular MalformationCompletedNCT02707484Phase 3
- Treatment of IgG4-Related Disease With Revlimid and RituximabCompletedNCT02705638Phase 1
- PRP vs Bevacizumab for PDR TreatmentCompletedNCT02705274Phase 2/3
- Bevacizumab and Nimustine in Patients With Recurrent High Grade GliomaCompletedNCT02698280Phase 2
- Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple MyelomaCompletedNCT02697344Phase 1
- Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis PatientsWithdrawnNCT02695641Early Phase 1
- Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid TumorsCompletedNCT02691793Phase 4
- Study to Assess Various Sunitinib Schedules in Renal Cell CarcinomaStatus unknownNCT02689167Phase 2
- Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular EdemaTerminatedNCT02684084Phase 4
- PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLiberceptStatus unknownNCT02681783Phase 4
- Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy TrialActive, not recruitingNCT02678182Phase 2
- Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation TrialStatus unknownNCT02672995Phase 1
- Capecitabine + Bevacizumab in Patients With Recurrent GlioblastomaCompletedNCT02669173Phase 1
- Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasStatus unknownNCT02665702Phase 2
- Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid TumorsCompletedNCT02665416Phase 1
- FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)CompletedNCT02661971Phase 2/3
- Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi SarcomaActive, not recruitingNCT02659930Phase 1
- Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple MyelomaActive, not recruitingNCT02659293Phase 3
- Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II TrialStatus unknownNCT02655536Phase 2
- Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple MyelomaCompletedNCT02655458Phase 1
- Study of Endostar Subcutaneous Injection in NSCLCStatus unknownNCT02652234Phase 1
- Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective StudyStatus unknownNCT02651168Phase 4
- Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast CancerStatus unknownNCT02649101Phase 2
- Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid TumorsTerminatedNCT02648711Phase 1
- Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular GlaucomaCompletedNCT02647515Phase 4
- Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular EdemaCompletedNCT02646670Phase 4
- The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular EdemaStatus unknownNCT02645734Phase 2/3
- Mean Visual Acuity Changes Following Five Injections of AfliberceptActive, not recruitingNCT02645266Not applicable
- A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal CancerCompletedNCT02641873Phase 1
- Intravitreal Aflibercept or Ranibizumab for Rubeosis IridisCompletedNCT02641457Phase 3
- CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumabWithdrawnNCT02634970Phase 4
- Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular EdemaCompletedNCT02633852Phase 4
- Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung CancerStatus unknownNCT02633189Phase 3
- Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioNStatus unknownNCT02630277Phase 2
- E10A for the Treatment of Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT02630264Phase 3
- Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic AnalysisCompletedNCT02628951Phase 2
- A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian PopulationTerminatedNCT02626754Phase 2
- Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line TreatmentStatus unknownNCT02624726Phase 2
- A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic CarcinomaCompletedNCT02623127Phase 2
- Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic CancerCompletedNCT02620800Phase 1
- A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple MyelomaCompletedNCT02616640Phase 1
- Anti-angiogenetic Therapy With Radiotherapy for Pediatric NeuroblastomaStatus unknownNCT02615106Phase 2
- Strategies for Management of Corneal NeovascularisationStatus unknownNCT02594423Phase 4
- Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal CancerStatus unknownNCT02591667Phase 2
- A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPCStatus unknownNCT02590133Phase 2
- STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTSCompletedNCT02586038Phase 2
- UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD CombinationWithdrawnNCT02578121Phase 2
- Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK CellsActive, not recruitingNCT02573896Phase 1
- Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).WithdrawnNCT02573038Phase 2
- A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic MalignanciesCompletedNCT02572687Phase 1
- HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple MyelomaCompletedNCT02569320Phase 1
- Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin LymphomaCompletedNCT02568553Phase 1
- Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA).CompletedNCT02556229Phase 2
- Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisStatus unknownNCT02555800Phase 2
- Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell CarcinomaCompletedNCT02555748Phase 4
- NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage ChemotherapyStatus unknownNCT02544724Phase 2
- Trial of Immunomodulatory Therapy in High Risk Solitary Bone PlasmacytomaActive, not recruitingNCT02544308Phase 3